HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 2 (HAI-2) MODULATES HEPCIDIN EXPRESSION BY INHIBITING CELL SURFACE PROTEASE MATRIPTASE-2

被引：0
|
作者：
Maurer, Eva [1 ]
Guetschow, Michael [1 ]
Stirnberg, Marit [1 ]
机构：
[1] Univ Bonn, Bonn, Germany
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2013年 / 88卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E50 / E50
页数：1
相关论文
共 50 条
  • [21] Underexpression of hepatocyte growth factor activator inhibitors HAI-1 and HAI-2 was associated with promoter hypermethylation in hepatocellular carcinoma.
    Tung, Kwok Kwan
    Wong, Chun-Ming
    Ng, Irene Oi-Lin
    CANCER RESEARCH, 2006, 66 (08)
  • [22] Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor
    Kawaguchi, T
    Qin, L
    Shimomura, T
    Kondo, J
    Matsumoto, K
    Denda, K
    Kitamura, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) : 27558 - 27564
  • [23] Characterization of transcripts generated from mouse hepatocyte growth factor activator inhibitor type 2 (HAI-2) and HAI-2-related small peptide (H2RSP) genes: chimeric mRNA transcribed from both HAI-2 and H2RSP genes is detected in human but not in mouse
    Naganuma, S
    Itoh, H
    Uchiyama, S
    Tanaka, H
    Nagaike, K
    Miyata, S
    Uchinokura, S
    Nuki, Y
    Akiyama, Y
    Chijiiwa, K
    Kataoka, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (02) : 345 - 353
  • [24] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
    Betsunoh, Hironori
    Mukai, Shoichiro
    Akiyama, Yutaka
    Fukushima, Tsuyoshi
    Minamiguchi, Naoki
    Hasui, Yoshihiro
    Osada, Yukio
    Kataoka, Hiroaki
    CANCER SCIENCE, 2007, 98 (04) : 491 - 498
  • [25] Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein
    Mitchell, Aaron C.
    Kannan, Deepti
    Hunter, Sean A.
    Sperberg, R. Andres Parra
    Chang, Cheryl H.
    Cochran, Jennifer R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (14) : 4969 - 4980
  • [26] Matriptase Does Not Require Hepatocyte Growth Factor Activator Inhibitor Type-1 for Activation in an Epithelial Cell Expression Model
    Miyake, Yuka
    Tsuzuki, Satoshi
    Fushiki, Tohru
    Inouye, Kuniyo
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (04) : 848 - 850
  • [27] Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity
    Chiu, Yi-Lin
    Wu, Yi-Ying
    Barndt, Robert B.
    Lin, Yu-Wen
    Sytwo, Hou-Ping
    Cheng, Amy
    Yang, Kacy
    Chan, Khee-Siang
    Wang, Jehng-Kang
    Johnson, Michael D.
    Lin, Chen-Yong
    GENES & DISEASES, 2022, 9 (04) : 1049 - 1061
  • [28] HGFA inhibitor type-2 (HAI-2) promotes invasive growth in OSCC through suppression of prostasin expression.
    Yamamoto, Koji
    Kawaguchi, Makiko
    Fukushima, Tsuyoshi
    Kataoka, Hiroaki
    CANCER SCIENCE, 2018, 109 : 316 - 316
  • [29] Expression of Hepatocyte Growth Factor Activator Inhibitor Type-1 (HAI-1) in Prostate Cancer
    Yasuda, Kenji
    Komiya, Akira
    Watanabe, Akihiko
    Morii, Akihiro
    Oya, Takeshi
    Nagakawa, Osamu
    Fujiuchi, Yasuyoshi
    Fuse, Hideki
    ANTICANCER RESEARCH, 2013, 33 (02) : 575 - 581
  • [30] Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract
    Lei Zeng
    World Journal of Gastroenterology, 2005, (39) : 6202 - 6207
12345